Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
qualitestrx.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Qualitest Pharmaceuticals

Qualitest Pharmaceuticals is engaged in the manufacture and distribution of generic pharmaceuticals in the US

Qualitest Pharmaceuticals Headquarter Location

130 Vintage Drive

Huntsville, Alabama, 35811,

United States

Latest Qualitest Pharmaceuticals News

Endo International's Qualitest to Lay Off 300 in Shuttering of Its North Carolina Facility

Nov 4, 2016

   View More Jobs Charlotte, N.C. — An Irish pharmaceutical company will lay off close to 300 employees by Dec. 31 with the closing of its Charlotte operations, according to a filing with the North Carolina Department of Commerce. Qualitest Pharmaceuticals, a subsidiary of Dublin-based Endo International, filed a WARN Act notice on Nov. 2, listing the 282 jobs that will be permanently terminated. All affected employees have been notified of their permanent separation, and all separations are expected to be accomplished by Jan. 14, 2017.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Qualitest Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Qualitest Pharmaceuticals is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.